XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Cash flows from operating activities:          
Net income (loss) $ (3,191,000) $ 956,000 $ (3,190,000) $ 1,503,000  
Adjustments to reconcile net income (loss) to net cash used in operating activities:          
Income from cash and investments held in Trust Account     (527,000) (2,899,000)  
Amortization of debt discount 45,000 45,000  
Change in fair value of warrant liability 410,000 (615,000) 410,000 820,000  
Change in fair value of conversion feature (72,000) (72,000)  
Wavier of deferred underwriting compensation related to warrant portion of public offering (258,000) (258,000)  
Changes in operating assets and liabilities:          
(Increase) decrease in prepaid expenses     (58,000) 76,000  
Increase in accounts payable     70,000 20,000  
Increase in accrued liabilities and other     2,342,000 24,000  
Net cash used in operating activities     (1,238,000) (456,000)  
Cash flows from investing activities:          
Cash deposited in Trust Account     (209,000)  
Cash withdrawn from Trust Account     187,475,000  
Net cash (used) provided from investing activities     (209,000) 187,475,000  
Cash flows from financing activities:          
Redemption of 17,910,004 Class A ordinary shares     (187,475,000)  
Cash received from Promissory note to related party     1,750,000  
Cash received from notes payable to related party     275,000  
Net cash (used) provided by financing activities     2,025,000 (187,475,000)  
Net change in cash     578,000 (456,000)  
Cash and cash equivalents at beginning of period     14,000 744,000 $ 744,000
Cash and cash equivalents at end of period $ 592,000 $ 288,000 592,000 288,000 $ 14,000
Supplemental disclosure of non-cash financing activities:          
Termination of note payable to prior Sponsor     525,000  
Forgiveness of Former Sponsor accrual deemed a capital contribution     30,000  
Waiver of deferred underwriting compensation deemed a capital contribution for equity portion of public offering     3,417,000  
Remeasurement of carrying value to redemption value of Class A ordinary shares subject to redemption     $ 736,000 $ 2,899,000